Prisma Health Ketamine Injection Recall: Incorrect Expiry Dates
Prisma Health recalls ketamine injections with incorrect expiry dates. Products may expire before intended use, risking ineffective treatment or safety issues.
Lower-risk recall
Labeling: Incorrect Exp. Date: Incorrect BUD.
Contact the company
What happened, in plain English
Prisma Health is recalling ketamine injections that have incorrect expiration dates. Using these products could lead to ineffective treatment or safety risks if the medication expires before intended use. Read more at govinfonow.com/recall/36124-prisma-health-ketamine-injection-recall-incorrect-expiry-dates.
Source Summary by GovInfoNow · govinfonow.com/recall/36124-prisma-health-ketamine-injection-recall-incorrect-expiry-dates · Updated August 18, 2026 · FDA enforcement record: FDA #D-0648-2021
Cite this page
“Prisma Health Ketamine Injection Recall: Incorrect Expiry Dates.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36124-prisma-health-ketamine-injection-recall-incorrect-expiry-dates. Based on FDA recall #D-0648-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0648-2021%22&limit=1).
Why it’s dangerous
The injections have incorrect expiration dates (BUD) which means they may expire before the intended use date. This could result in the medication becoming ineffective or unsafe for patient use.
Who’s affected
Patients prescribed ketamine injections by healthcare providers at Prisma Health's outsourcing facility in Simpsonville, SC. Those using the recalled products are most at risk.
How to tell if you have this one
Check for the product name 'Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL)' compounded by Prisma Health Outsourcing Facility. Look for lot numbers K10521042 or K20521043 with an expiration date of 08/31/2021.
- Brand
Prisma Health- Category
Drug
What to do — step by step
Check Expiration Date
Verify the expiration date on the label matches the intended date (08/31/2021).
Contact Healthcare Provider
Reach out to your healthcare provider for guidance on whether to use the product.
Where it went and when
Where it was distributed
Distributed in South Carolina.
FDA distribution: “Distributed in South Carolina” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: South Carolina.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class III
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0648-2021 (June 8, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0648-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.